Skip to main content

Table 3 Baseline characteristics of patients receiving aminophylline vs those not receiving Aminophylline

From: Assessment of global myocardial perfusion reserve using cardiovascular magnetic resonance of coronary sinus flow at 3 Tesla

Characteristic Aminophylline No Aminophylline P Value
  (n = 41) (n = 67)  
Age ± SD 63 ± 17 59 ± 17 0.24
Male sex (%) 22 (54) 28 (42) 0.31
Caucasian (%) 9 (22) 11 (16) 0.54
Diabetes (%) 8 (20) 26 (39) 0.06
Hypertension (%) 31 (76) 48 (72) 0.90
Hyperlipidemia (%) 26 (63) 32 (48) 0.17
Current smoker (%) 8 (20) 13 (19) 0.93
10 yr Framingham risk ± SD 24 ± 14 23 ± 20 0.75
Baseline heart rate 71 ± 12 69 ± 15 0.47
Baseline blood pressure:    
Systolic 129 ± 19 124 ± 14 0.12
Diastolic 66 ± 15 68 ± 19 0.57
Peak heart rate 96 ± 17 93 ± 18 0.39
Peak blood pressure:    
Systolic 126 ± 18 125 ± 15 0.76
Diastolic 63 ± 15 67 ± 18 0.24
  1. BMI = body/mass index; CAD = coronary artery disease; SD = standard deviation. MPR was calculated as peak CS flow/pre CS flow.